You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reticulocytes

Showing 1 - 25 of 353
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Insufficiency, Chronic Trial in France (Reticera)

Terminated
  • Renal Insufficiency, Chronic
  • Reticera
  • Angers, France
  • +8 more
Mar 3, 2022

Immunological Pure Red Cell Aplasia Trial (Isatuximab)

Not yet recruiting
  • Immunological Pure Red Cell Aplasia
  • (no location specified)
Sep 26, 2022

HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)

Not yet recruiting
  • HIV Infections
  • Cabotegravir Formulation F
  • Cabotegravir Formulation G
  • Austin, Texas
    GSK Investigational Site
Sep 4, 2023

Chronic Kidney Disease Trial in Ho Chi Minh City (Stimus)

Active, not recruiting
  • Chronic Kidney Disease
  • Stimus
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Nov 23, 2022

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Causes and Mechanisms of Space Hemolysis at High Altitudes

Recruiting
  • Anemia
  • Weightlessness
    • Ottawa, Ontario, Canada
      Ottawa Hospital Research Institute
    Aug 10, 2022

    AI Based Multi-modal Parameter of Peripheral Blood Cells

    Recruiting
    • Children
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      Sep 12, 2023

      HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))

      Recruiting
      • HIV Infections
      • Cabotegravir 200 mg/mL
      • +2 more
      • Orlando, Florida
      • +3 more
      Dec 1, 2022

      HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))

      Not yet recruiting
      • HIV Infections
      • Cabotegravir IR Formulation (reference)
      • +2 more
      • (no location specified)
      Mar 8, 2023

      Sickle Cell Trait (AUNT)

      Recruiting
      • Sickle Cell Trait
      • Biologic Specimen Collection
      • Birmingham, Alabama
      • +5 more
      Oct 4, 2023

      Solid Tumor, Adult, Anemia Deficiency Trial in Saint Herblain (Haemoglobin measure)

      Completed
      • Solid Tumor, Adult
      • Anemia Deficiency
      • Haemoglobin measure
      • Saint Herblain, France
        Institut de Cancérologie de l'Ouest
      Apr 19, 2021

      Plasmapheresis, Haematology, Sport Performance Trial in Louvain-la-Neuve (Plasmapheresis)

      Completed
      • Plasmapheresis
      • +6 more
      • Plasmapheresis
      • Louvain-la-Neuve, Brabant Wallon, Belgium
        UCLouvain
      Apr 3, 2023

      Inflammation; Muscle, Iron Metabolism, Ineffective Erythropoiesis Trial (Cholecalciferol, )

      Completed
      • Inflammation; Muscle
      • +3 more
      • (no location specified)
      May 18, 2023

      Retrospective Real World Oxbryta® Data Collection and Analysis

      Completed
      • Sickle Cell Disease
      • Oxbryta® (voxelotor) 500-mg Tablets
      • Farmington, Connecticut
      • +8 more
      Sep 6, 2022

      Sickle Cell Disease Trial (open-label GBT021601)

      Not yet recruiting
      • Sickle Cell Disease
      • open-label GBT021601
      • (no location specified)
      Nov 21, 2022

      FID and QoL in Oncological and With Haematological Malignancies

      Recruiting
      • Functional Iron Deficiency
        • Luzern, Switzerland
          Luzerner Kantonsspital
        Apr 16, 2022

        Sickle Cell Disease Trial in Little Rock (GBT021601)

        Recruiting
        • Sickle Cell Disease
        • Little Rock, Arkansas
          Lynn Institute of the Ozarks
        Aug 10, 2022

        Validation of a Predictive Score of Acute Chest Syndrome

        Recruiting
        • Vaso Occlusive Crisis
        • Acute Chest Syndrome
          • Creteil, France
            Henri Mondor Hospital
          Dec 12, 2022

          Asthma Trial (Salbutamol HFA-152a, Salbutamol HFA-134a)

          Not yet recruiting
          • Asthma
          • Salbutamol HFA-152a
          • Salbutamol HFA-134a
          • (no location specified)
          Mar 17, 2023

          Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)

          Not yet recruiting
          • Serum Ferritin
          • Collection of Blood samples
          • Basel, Switzerland
            University Hospital Basel
          Jun 5, 2023

          Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

          Recruiting
          • Sickle Cell Disease
          • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 20, 2023

          Sickle Cell Disease Trial in United States (Oxbryta® (voxelotor) 500mg Tablets)

          Recruiting
          • Sickle Cell Disease
          • Oxbryta® (voxelotor) 500mg Tablets
          • Palo Alto, California
          • +9 more
          Dec 15, 2022

          Asthma Trial (GSK3511294)

          Active, not recruiting
          • Asthma
          • GSK3511294
          • Hangzhou, Zhejiang, China
            GSK Investigational Site
          Oct 21, 2022

          Bone Marrow Suppression and Recovery During Radionuclide

          Completed
          • Castration-resistant Prostate Cancer
          • Blood sampling
          • Copenhagen, Denmark
            Rigshospitalet
          Nov 4, 2022

          Fabry Disease Trial in Buenos Aires (Recombinant human alpha galactosidase A (agalsidase beta), Recombinant human

          Recruiting
          • Fabry Disease
          • Recombinant human alpha galactosidase A (agalsidase beta)
          • Recombinant human alpha-galactosidase A (agalsidase beta)
          • Buenos Aires, Argentina
            Instituto de Investigaciones Clínicas Quilmes
          Apr 24, 2023